XML 36 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Expenses:    
Research and development $ 30,324 $ 18,572
General and administrative 13,227 10,026
Total operating expenses 43,551 28,598
Loss from operations (43,551) (28,598)
Other income (expense):    
Grant income 22,217 17,447
Change in the fair value of the derivative liability   2,209
Change in the fair value of the Simple Agreements for Future Equity   (2,236)
Other income (expense), net (35) (88)
Gain on debt extinguishment   443
Interest expense (28) (893)
Total other income, net 22,154 16,882
Net Loss (21,397) (11,716)
Cumulative preferred stock dividends   (4,532)
Net loss attributable to common stockholders (21,397) (16,248)
Unrealized loss on foreign currency translation (1) (11)
Total comprehensive loss $ (21,398) $ (11,727)
Net loss per share, basic (in dollars per share) $ (0.91) $ (3.13)
Net loss per share, diluted (in dollars per share) $ (0.91) $ (3.13)
Weighted-average common shares outstanding, basic (in shares) 23,640,199 5,190,883
Weighted-average common shares outstanding, diluted (in shares) 23,640,199 5,190,883